Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

121.91
Delayed Data
As of 4:00pm ET
 +3.24 / +2.73%
Today’s Change
102.10
Today|||52-Week Range
149.34
+1.94%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Oneill Julie /alexion/
Sale8/28/201711,160$140.00$1.6M-14.64%
Hantson Ludwig N
Chief Executive Officer
Sale2/08/201813,245$116.31$1.5M+9.40%
Coughlin Christopher J
Director
Buy4/30/201810,000$120.79$1.2M+0.88%
Coughlin Christopher J
Director
Gift12/05/201710,000$112.75$1.1M+8.97%
Clancy Paul J
Chief Financial Officer & Executive Vice President
Sale2/08/20186,079$116.31$707.0K+9.40%
Oneill Julie /alexion/
Sale2/08/20184,787$116.31$556.8K+9.40%
Hantson Ludwig N
Chief Executive Officer
Sale1/02/20182,553$121.63$310.5K-4.34%
Oneill Julie /alexion/
Sale9/05/20171,841$145.81$268.4K-18.00%
Orloff John J
EVP-Research & Development
Sale6/08/20182,115$118.53$250.7K+0.29%
Moriarty John B Jr
General Counsel & Executive Vice President
Sale2/08/20182,163$115.70$250.3K+9.40%
Page of 7